pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 4·1 min read
save

Patient finds open-source diabetes app improves control despite lack of FDA approval

Aug 4, 2026·read at STAT ↗Positive

Patient has type 1 diabetes for over 30 years and has used FDA-approved pumps and sensors that were upgraded roughly every five years. Over time his glucose control slipped despite the regulated devices.

His doctor suggested trying an open-source software platform that links the sensor to the insulin pump. The community-written code adjusts insulin delivery more precisely than the commercial apps, allowing him to meet clinical guidelines and feel much better. The program is free and runs on his iPhone.

He acknowledges the gamble of using software outside FDA oversight. The agency treats medical software as a device to ensure safety, but the approval process is expensive and slow, leaving innovative tools unregulated.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: I’m using not-FDA-approved software to manage my diabetes. I’ve never felt better”

read at STAT ↗
907 words · retrieved Aug 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLE
drugs
insulin4
topics
Type 2 Diabetes6Type 1 Diabetes2ALSApproval

related stories

  • Sep 9Caspian launches with $50M, Lilly support to advance disease-modifying diabetes betBioSpace
  • Sep 9Kura creates Lilly-backed spinout armed with $50M to advance next-gen diabetes therapyFierce Biotech
  • Aug 18Amylyx’s bet on a GLP-1 blocker pays offBioPharma Dive
  • Jul 20Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceBioSpace
  • Jul 8Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsSTAT